← FDA Drug Approvals (Drugs@FDA)
CITALOPRAM HYDROBROMIDE
NDA · New Drug Application · Sponsor: ALMATICA · Approved 2022-01-31
Drug application
- FDA Application #
NDA215428- Application type
- New Drug Application
- Brand name
- CITALOPRAM HYDROBROMIDE
- Generic name
- CITALOPRAM
- Active ingredients
- CITALOPRAM HYDROBROMIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ALMATICA
- Manufacturer
- Almatica Pharma LLC
- First approval
- 2022-01-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown